Efficacy and Safety of Cladribine Combined With BEAC Pretreatment Regimen in the Treatment of Peripheral T-cell Lymphoma: a Multicenter Clinical Study

NCT04880746 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

266

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T-cell Lymphoma

Interventions

DRUG: BEAC
DRUG: Cladribine combined with BEAC

Sponsor

Ruijin Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]